The FDA just gave the green light to a second Phase 1a/b IND for ST-001, SciTech’s investigational fenretinide nanoparticle therapy—this time for patients with SCLC. #lungcancer
https://firstwordpharma.com/story/5948449

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service